Cultured Allogeneic Skin Cells are Effective in the Treatment of Chronic Diabetic Leg and Foot Ulcers

Harvima, Ilkka T.; Virnes, Suoma; Kauppinen, Leena; Huttunen, Maria; Kivinen, Petri; Niskanen, Leo; Horsmanheimo, Maija
May 1999
Acta Dermato-Venereologica;5/27/99, Vol. 79 Issue 3, p217
Academic Journal
Diabetic ulcers on the lower extremities present a difficult treatment problem, and some ulcers respond poorly to conventional topical and cast treatment. The purpose of this study was to assess the effect of cultured allogeneic keratinocyte epithelium and fibroblast-gelatin sponge on the healing of chronic, refractory diabetic leg and foot ulcers. Non-diabetic chronic leg ulcers were treated for comparison. This open study comprised 22 patients with type I or type II diabetes and 16 patients with leg or ankle ulcers of different aetio-logies. A total of 26 diabetic and 25 non-diabetic ulcers were treated mainly with keratinocyte epithelium and/or fibroblast-gelatin sponge once weekly until complete healing or until no further healing could be observed despite several repeated treatments. The duration of diabetic ulcers was 10.3±15.8 (mean±SD) months and the size 3.1±6.6 cm[sup 2]. The diabetic ulcers were located in the heel (7), toe (7), sole (5), leg (6) and Achilles (1). The mean duration of non-diabetic ulcers was 6.8±6.0 months and the size 10.5±11.8 cm[sup 2]. A total of 12±11 skin cell transplantations were performed for the diabetic ulcers. All but 1 diabetic ulcer healed during the study. The time for 50% reduction in ulcer area was 32±32 days, but 99±110 days were needed for complete ulcer closure. The longer the ulcer had existed the longer was the healing time. Heel ulcers showed significantly slower healing response than leg, sole and toe ulcers. Preliminary results suggest that both keratinocytes and fibroblasts are equally effective in the healing process. The time required for healing of the diabetic ulcers did not differ markedly from that of the non-diabetic ulcers. The results suggest that cultured allogeneic skin cells used once weekly are effective in the treatment of recalcitrant diabetic ulcers.


Related Articles

  • New treatments for lower extremity ulcers. Brown, Anne B. // Patient Care for the Nurse Practitioner;Dec2001, Vol. 4 Issue 12, p9 

    Presents guidelines on the treatment of lower extremity ulcers in diabetic patients. Characteristics to be determined in performing an assessment of ulcers; Therapeutic interventions in treating nonhealing wounds; Methods of debridement which can be used.

  • Effect of Dalteparin on Healing of Chronic Foot Ulcers in Diabetic Patients With Peripheral Arterial Occlusive Disease. Kalani, Majid; Apelqvist, Jan; Blombäck, Margareta; Brismar, Kerstin; Eliasson, Björn; Eriksson, Jan W.; Fagrell, Bengt; Hamsten, Anders; Torffvit, Ole; Jörneskog, Gun // Diabetes Care;Sep2003, Vol. 26 Issue 9, p2575 

    OBJECTIVE — Chronic foot ulcers are a common, severe, and expensive complication threatening life and limb in patients with diabetes. The aim of the present study was to investigate the effect of dalteparin on ulcer outcome in patients with diabetes, peripheral arterial occlusive disease,...

  • Efficacy of topical recombinant human platelet derived growth factor on wound healing in patients with chronic diabetic lower limb ulcers. Jaiswal, Shyam; Gambhir, R.; Agrawal, Amit; Harish, S // Indian Journal of Surgery;Feb2010, Vol. 72 Issue 1, p31 

    Lower extremity ulcers are a serious complication of diabetes mellitus (DM). These ulcers show decreased angiogenic response and production of growth factors. Recombinant human platelet derived growth factor (rhPDGF) has been found to decrease the time to healing. This study was conducted to...

  • Intermittent Pneumatic Compression Promoted Healing in Foot Infections. Armstrong, D.G.; Nguyen, H.C // Journal of Bone & Joint Surgery, American Volume;May2001, Vol. 83-A Issue 5, p787 

    Question: In patients who have diabetes mellitus and edema with foot ulcers requiring débridement, how effective is intermittent pneumatic foot compression after débridement in promoting wound-healing? Design: Randomized, double-blind, placebo-controlled trial with 12-week follow-up....

  • Study gives credence to Sanuwave's PACE tech. FORD, OMAR // Medical Device Daily;10/22/2010, Vol. 14 Issue 206, p1 

    The article focuses on a study which examined how Pulsed Acoustic Cellular Expression (PACE) treatment of Sanuwave benefits ischemic conditions at the tissue and cellular levels following surgical trauma. The study found that PACE treatment can immediately increase blood vessel diameters of...

  • Debridement of diabetic foot wounds. Haycocks, Samantha; Chadwick, Paul // Nursing Standard;2/15/2012, Vol. 26 Issue 24, p51 

    The management of foot ulcers in patients with diabetes is a complex and increasingly common problem. This article outlines the core principles of best practice for these patients focusing, in particular, on debridement. The article defines debridement, looks in detail at the rationale and...

  • The sweet solution. Harrison, Michael // CMAJ: Canadian Medical Association Journal;12/11/2001, Vol. 165 Issue 12, p1622 

    Presents a treatment of a chronic, indolent diabetic foot ulcer related to diabetic neuropathy, vascular deficiency and prominent metatarsal. Use of granulated sugar held in place with dry dressings to rapidly heal the wound; Possible use of honey on some wounds.

  • Cost effectiveness of Becaplermin in the treatment of diabetic foot ulcers in four European countries. Ghatnekar, O.; Persson, U.; Willis, M.; Odegaard, K. // PharmacoEconomics;Jul2001, Vol. 19 Issue 7, p767 

    Objective: The primary objective of this study was to estimate the cost effectiveness of treating diabetic foot ulcers with becaplermin (Regranex) plus good wound care (GWC) compared with GWC alone in a variety of European healthcare settings. A secondary objective was to analyse...

  • Diabetes and Orthopaedic Surgery. Paola, Luca Dalla; Carone, Anna; Ricci, Silvia; Russo, Andrea // Advances in Orthopaedics;Sep2010, Vol. 2 Issue 3, p89 

    Diabetic foot is a major health problem all over the world. Approximately 15% of the 200 million people with diabetes worldwide will develop a foot ulcer during their lifetime. Major amputation is a feared complication of diabetes. More than 60% of non-traumatic amputations in the western world...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics